Genetics

Is the first commercial gene therapy product within sight?

Highly anticipated phase III clinical trial results of Spark Therapeutics's gene therapy to treat visual impairment are due by year-end and could have profound implications for the broader gene therapy field, leading to the ...

Psychology & Psychiatry

Echolocation acts as substitute sense for blind people

Recent research carried out by scientists at Heriot-Watt University has demonstrated that human echolocation operates as a viable 'sense', working in tandem with other senses to deliver information to people with visual impairment.

Ophthalmology

Simple test could detect serious eye condition early

A simple colour test that could detect the early onset of a condition which accounts for over half of visual impairment certifications in the UK is being researched by scientists at Aston University.

page 10 from 17